Atovaquone
- TRADE NAMES: Mepron (GSK); Wellvone (GSK)
- INDICATIONS: Pneumocystis carinii infection
- CLASS: Antimalarial, Antimicrobial, Antiprotozoal
- HALF-LIFE: 1.5–4 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Efavirenz, Etoposide, Histamine, Hypoglycemic agents, Indinavir, Lopinavir, Metoclopramide, Rifabutin, Rifampin, Rifapentine, Ritonavir, Tetracycline, Zidovudine
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric